knowledge -WSS

knowledge

author：fashion 2025-09-07 14:00:51 - browse：52349

light shines behind Pfizer CEO Albert Bourla as he attends a ceremony in Greece — Pfizer CEO Albert Bourla Giannis Papanikos/AP

Pfizer has a big problem. The drug giant hopes that new drugs to treat cancer are the solution.

Shares in the drugmaker fell 44% last year, and it now has a market capitalization of only $150 billion — a quarter that of Eli Lilly and half that of longtime rival Merck. In March of last year the company announced that it would spend $43 billion to buy Seagen, a maker of a hot category of oncology medicines called antibody-drug conjugates. Pfizer’s shares have slumped another 9% so far this year. On Thursday, executives are holding an investor briefing to try to convince shareholders that its bet will pay off.

In an interview with STAT, Pfizer CEO Albert Bourla was insistent that the deal’s potential is being missed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： SCOTUS questions limit to govt efforts to fight misinformation

WSS

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

Health AI adoption puts security, privacy startups on investors' radar

Ford recalls 870K F

CDC: Cases of alpha

Biden jokes that Republicans may impeach him because inflation is starting to cool down

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

entertainment

knowledge

focus

Psychedelics group wrestles with new pharma identity

5 to watch: Tech startups trying to solve health care's staffing crisis

Moonlake's readout produced a cash windfall. Risks remain

Orchard's therapy for neuron disease in children wins FDA approval

The high cost of giving birth even with insurance

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Medicare proposal to cover medical devices draws a mixed reaction

Stop the failed accountable care organization experiment

Heart attack and stroke risk calculators need revising

Interest rates are at a 22

focus

Intermittent fasting comes with a heart risk? Not so fast

Asbestos, a deadly carcinogen, banned by EPA

Creating egg and sperm cells from stem cells raises ethical issues

Health AI adoption puts security, privacy startups on investors' radar

Baby aspirin cuts fat buildup in liver disease patients, in small study

Ending health disparities requires full federal government, panel says

explore

Wikipedia

knowledge

focus